Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03641378 · ClinicalTrials.gov registry record · NA
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation
A NA study of Stem Cell Transplant, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 3
- Study locations
NCT03641378: Completed NA study of Stem Cell Transplant, sponsored by Massachusetts General Hospital.
NCT03641378 is a NA study of Stem Cell Transplant that has completed, run by Massachusetts General Hospital. The registered enrollment target is 546 participants, above the 136-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (301% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03641378, a NA study of Stem Cell Transplant, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the impact of early involvement of a palliative care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.
Primary Outcome
Compare patient QOL using the Functional Assessment of Cancer Therapy- Bone Marrow Transplant (FACT-BMT) scores at week 2 between the study groups Score range 0-164 with higher score indicating better quality of life
Conditions Studied
Interventions
- OTHER Palliative Care Intervention
- OTHER Standard Transplant Care
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Duke University - Durham
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2018-09-30 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT03641378 record still lists
NCT03641378 is an interventional study that assigns participants to a tested intervention. The registered 546 participants enrollment target is mid-sized for trials with a published cap, above the 136-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (301% higher).
The record links to 1 condition, with Stem Cell Transplant appearing as the primary indexed condition, and to 2 interventions - of which Palliative Care Intervention is the first listed.
NCT03641378 reports a single indexed study location in Massachusetts, North Carolina, Washington.
Frequently Asked Questions
What is clinical trial NCT03641378 about?
NCT03641378 is a clinical study titled "Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation". This research study is evaluating the impact of early involvement of a palliative care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.
What is the current status of trial NCT03641378?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2018-09-30. Estimated completion is 2023-07-01.
What conditions does trial NCT03641378 study?
This clinical trial studies the following conditions: Stem Cell Transplant.
What interventions are being tested in trial NCT03641378?
The interventions under investigation include: Palliative Care Intervention (OTHER), Standard Transplant Care (OTHER).
Who is sponsoring clinical trial NCT03641378?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03641378 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03641378's enrollment target sits among peer trials
546 1st of 9 higher than 9 of 9 other Stem Cell Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
RECRUITING · NA
-
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
RECRUITING · NA
-
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
RECRUITING · NA
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Mosaic Trial for Stem Cell Transplant Recipients
RECRUITING · NA
-
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI